Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record's update history shows new timestamps for 2026-07-08 and 2026-07-07, and older entries were removed; this reflects maintenance of the log rather than changes to the study details.
    Difference
    0.2%
    Check dated 2026-07-12T17:49:40.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.3) dated 2026-07-02 was added, and the prior revision (v3.6.2) from June 2026 was removed. This reflects routine maintenance of the study record’s version history rather than substantive changes to the study details.
    Difference
    0.2%
    Check dated 2026-07-05T14:27:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.0 to v3.6.2, reflecting an internal update to the page. This change does not affect the study details, eligibility criteria, or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-28T08:32:50.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    New navigation links were added to help users find who can join, contact information, how to read a study record, common questions, and how to join, and a version stamp 'Revision: v3.6.0' was introduced. The existing 'Intervention / Treatment' label was updated to 'Intervention/Treatment' to standardize terminology.
    Difference
    0.5%
    Check dated 2026-06-13T17:53:34.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study page was updated to include a new revision tag (v3.5.5) and show recent update dates (2026-06-04, 2026-06-05). This indicates the record has been refreshed or versioned recently for tracking purposes.
    Difference
    0.3%
    Check dated 2026-06-06T14:27:13.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Two new update entries dated 2026-05-20 and 2026-05-22 were added to the study record's update history. Entries dated 2026-05-06 and 2026-05-07 were removed from the history, altering the visible timeline of recent changes.
    Difference
    0.2%
    Check dated 2026-05-23T09:30:31.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.